ARTICLE | Clinical News
Zilretta regulatory update
December 14, 2016 11:05 PM UTC
Flexion said it submitted an NDA to FDA for Zilretta sustained-release triamcinolone acetonide to treat pain associated with osteoarthritis (OA) of the knee. Zilretta has Fast Track designation in the...
BCIQ Company Profiles